Chronic Liver Diseases Therapeutics Report

By www.reliablemarketforecast.com

Report Details

Report Name

Global Chronic Liver Diseases Therapeutics Market Size, Status And Forecast 2024-2031 Story

Pages

116

Price

$ 3900

Features

Chronic Liver Diseases Therapeutics Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Astellas Pharma
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
F. Hoffmann-La Roche
Merck
Novartis
Sanofi
Pfizer
Takeda Pharmaceutical
Bausch Health
Theratechnologies
Alnylam Pharmaceuticals
Protagonist Therapeutics
Dicerna Pharmaceuticals
Endo International
Provectus Biopharmaceuticals
MAX BioPharma